(Q71437767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

J I Weitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 November 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

Journal of Vascular and Interventional Radiology

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

6 Pt 2 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

19S-23S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

Studies on the kinetics of plasminogen activation by tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971243-X

7 January 2021

10.1016/S1051-0443(95)71243-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8770837%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference